info@iyrinhealth.com
About Kachhela Medex Private Limited
Kachhela Medex Private Limited, established in 2015, is a Private Limited Company. It is incorporated under the Companies Act and classified as a non-government entity. Registered with the Registrar of Companies in Mumbai, the company is engaged in the wholesale and exporting of medicines and other pharmaceutical products [1].
Company Overview
- Corporate Identification Number (CIN): U52100MH2015PTC271064
- Incorporation Date: 16 December 2015
- Registered Office: Shop no. 335, 1st Floor Sandesh Dawa Bazaar, Near Haj House, Ganjipeth, Nagpur, Maharashtra, India – 440018.
| Category | Company limited by shares |
| Sub Category | Non-government company |
| Company Class | Private |
| Registration Number | 271064 |
Company Profile
Kachhela Medex Private Limited is a privately held company focused on the non-specialized retail trade. The company is governed by the Companies Act and is classified as a non-government company, ensuring that its operations and financials are in line with the regulatory standards set forth by the Ministry of Corporate Affairs (MCA) [2].
Financial Highlights
As of the latest filings, Kachhela Medex Private Limited’s balance sheet was last updated on March 31, 2023. The company’s authorized and paid-up share capital stands at Rs. 100,000 each, reflecting its stable financial position. The company’s Annual General Meeting (AGM) was last held on November 29, 2021.
Board of Directors
The company was promoted by Mamta Anil Gangwani and Anilkumar Nanakram Gangwani, who hold key positions in management.
Kachhela Medex Pvt Ltd’s Medications Available At IyrinHealth
At IyrinHealth, we offer Tapaday, a brand of Tapentadol marketed by Kachhela Medex Pvt Ltd. Tapaday is an opioid analgesic indicated for the management of moderate to severe pain. It is available in two formulations to address different pain management needs:
- Tapaday Immediate Release (100 mg)- This formulation is designed for the relief of short-term, acute pain, providing rapid onset of action.
- Tapaday Extended Release (200 mg)- This version is formulated for the management of chronic pain, offering a prolonged therapeutic effect for sustained relief.
Both formulations are tailored to meet the specific needs of patients depending on the duration and nature of their pain.
References
- Kachhela Medex Private Limited, medicinesdropshipper.
- Kachhela Medex Private Limited, Indiafilings.
